(I-BusinessNews.Com, July 16, 2021 ) The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes, and ongoing innovations in mice models are driving the growth of the global mice model industry.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308
Inbred mice accounted for the largest share in the mice model market in 2019.
Based on the mice type, the mice model market is categorized into the inbred mice, outbred mice, conditioned/surgically modified mice, hybrid/congenic mice, genetically engineered mice, and spontaneous mutant mice segments. Â The inbred mice segment accounted for the largest share of the mice model market in 2019. The increasing use of inbred mice for the production of monoclonal antibodies, growing research application of inbred mice in pharmacology and cardiovascular disease studies, are the primary factors driving the growth of this segment.
Oncology Studies accounted for the largest share in the mice model market in 2019
Based on application, the mice model market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies segment is further segmented into diabetes and other endocrine metabolic disease. Oncology studies accounted for the largest share of the market in 2019. Increasing prevalence of cancer, a large number of research activities in the field of cancer, and growing implications of mice models in the study of various cancers are expected to drive market growth.
Breeding Â accounted for the largest share the mice model market in 2019
Based on services, the mice model market is segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services (surgical, line rescue, and in vivo pharmacology services). Of all these segments, the breeding services segment accounted for the largest share of the mice model market in 2019. The use of mice models for biomedical and pharmaceutical research has resulted in a growing need for expertise in breeding mutant, transgenic, gene-targeted, and other types of mice. As a result, several companies are providing breeding and other related services to meet growing demand.
CRISPR/Cas9 accounted for the largest share of the mice model market
Based on the type of technology used to create transgenic mice, the mice model market is categorized into the CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (includes virus/vector-mediated gene transfer, and TALENs & ZFNs) segments. CRISPR is the most widely used technology in the mice model market and contributed to the largest share of the mice model market in 2020. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.
Cages segment accounted for the largest share of the mice model market
Based on mice care products, the mice model market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). In 2019, the cages segment accounted for the largest share of the mice model market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.
North America accounted for the largest share of the mice model market in 2019.
Based on the region, the global mice model market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the mice model market. The large share of the North America region can be attributed to the presence of major players operating in the mice model market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
The major players operating in this market Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), Harbour Biomed (US) among others
Mr. Aashish Mehra